{"title":"Du nouveau pour les articulations et le psoriasis","authors":"Jean-Marie Manus","doi":"10.1016/S1773-035X(26)76712-5","DOIUrl":"10.1016/S1773-035X(26)76712-5","url":null,"abstract":"<div><h3>Résumé</h3><div><strong>Un arrêté au <em>Journal officiel</em> du ministère de la Santé signale la spécialité Fubelv® (étanercept, laboratoire Biogaran), intéressante à plusieurs titres</strong>.</div></div>","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Page 13"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148657076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Covid-19, un comprimé pour la prévention post-exposition","authors":"Jean-Marie Manus","doi":"10.1016/S1773-035X(26)76701-0","DOIUrl":"10.1016/S1773-035X(26)76701-0","url":null,"abstract":"","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Page 6"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148657151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Complément d’enquête","authors":"Aurélien Bauduin, Caroline Poli, Charline Miot, Céline Beauvillain, Émeline Vinatier","doi":"10.1016/S1773-035X(26)76721-6","DOIUrl":"10.1016/S1773-035X(26)76721-6","url":null,"abstract":"<div><h3>Résumé</h3><div>Le déficit en C6 est une immunodéficience rare touchant la voie terminale du complément, particulièrement décrite dans les populations d’origine africaine/afro-américaine où une prévalence plus élevée a été rapportée. Ce déficit, de transmission autosomique récessive, compromet la formation du complexe d’attaque membranaire (CAM), exposant les patients à un risque accru d’infections sévères à <em>Neisseria meningitidis</em>. Le diagnostic repose sur une exploration biologique du complément et une analyse génétique. La prise en charge inclut des mesures préventives essentielles, telles que les vaccinations anti-méningococciques, une antibioprophylaxie prolongée dans certains cas, et un suivi régulier pour limiter le risque de complications infectieuses.</div></div><div><h3>Abstract</h3><div>Complement component C6 deficiency is a rare primary immunodeficiency affecting the terminal complement pathway. It has been reported more frequently in individuals of African or African American ancestry, in whom a higher prevalence has been observed. This autosomal recessive disorder disrupts the formation of the membrane attack complex (MAC), thereby increasing susceptibility to invasive infections caused by <em>Neisseria meningitidis</em>. Diagnosis is based on functional complement assays, followed by molecular genetic testing confirming the diagnosis. Clinical management primarily relies on preventive strategies, including meningococcal vaccination, longterm antibiotic prophylaxis in selected patients, and regular clinical follow-up to mitigate the risk of recurrent invasive infections.</div></div>","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Pages 30-33"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148660962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gianni Di Vittorio, Leslie Bathomen, Anaïs Nombel, Lorna Garnier
{"title":"Lymphome T associé à une entéropathie (EATL) : une entité rare au croisement de l’immunologie et de l’hématologie","authors":"Gianni Di Vittorio, Leslie Bathomen, Anaïs Nombel, Lorna Garnier","doi":"10.1016/S1773-035X(26)76729-0","DOIUrl":"10.1016/S1773-035X(26)76729-0","url":null,"abstract":"<div><h3>Résumé</h3><div>La maladie coeliaque (MC) est une entéropathie auto-immune pouvant se compliquer en lymphome T associé à une entéropathie (EATL pour <em>Enteropathy-associated T-cell lymphoma</em>), notamment en cas de diagnostic tardif (forme paucisymptomatique), de forme réfractaire ou de mauvaise observance du régime sans gluten (RSG). Nous rapportons le cas d’un homme de 54 ans présentant une altération de l’état général avec amaigrissement, anomalies hépatiques et cytopénies, sans symptômes digestifs évocateurs. Une maladie coeliaque est ensuite diagnostiquée sur des arguments biologiques et histologiques. Dans ce contexte de maladie coeliaque diagnostiquée tardivement d’infiltration médullaire lymphocytaire monomorphe, le diagnostic d’EATL est retenu.</div></div><div><h3>Abstract</h3><div>Celiac disease is an autoimmune enteropathy that may be complicated by enteropathy-associated T-cell lymphoma (EATL), particularly in cases of latediagnosis (pauci-symptomatic form), or refractory form, or poor adherence to a gluten-free diet. We report the case of a 54-year-old man who presented with impaired of general condition with weight loss, abnormal liver function and cytopenias, without any suggestive gastrointestinal symptoms. Celiac disease was subsequently diagnosed based on biological and histological findings. In the context of late-diagnosed celiac disease, and monomorphic lymphocytic bone marrow infiltration, a diagnosis of EATL was made.</div></div>","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Pages 65-69"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Arthrite septique à Yersinia enterocolitica sur prothèse totale de hanche, à propos d’un cas et revue de la littérature","authors":"Albane Karkulowski, Asma Zribi, Camille Courboulès, Anne-Laure Roux","doi":"10.1016/S1773-035X(26)76730-7","DOIUrl":"10.1016/S1773-035X(26)76730-7","url":null,"abstract":"<div><h3>Résumé</h3><div>Nous rapportons un cas d’infection sur prothèse de hanche à <em>Yersinia enterocolitica</em> chez un patient ne présentant aucun facteur de risque. Ce cas est complété par une revue de la littérature des cas d’infections ostéo-articulaires sur matériel à <em>Yersinia enterocolitica</em> qui restent une affection rare.</div></div><div><h3>Abstract</h3><div>We report a case of hip prosthesis infection caused by <em>Yersinia enterocolitica</em> in a patient with no risk factors. We also conducted a literature review of osteoarticular infections involving prosthetic material due to <em>Yersinia enterocolitica</em>, which remain a rare condition.</div></div>","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Pages 70-74"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Stocks de sécurité de médicaments,: il faut une logique de flexi-sécurité","authors":"Jean-Marie Manus","doi":"10.1016/S1773-035X(26)76713-7","DOIUrl":"10.1016/S1773-035X(26)76713-7","url":null,"abstract":"","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Page 14"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Obligation vaccinale grippale : rappel pressant de l’Académie de médecine aux professionnels de santé","authors":"Jean-Marie Manus","doi":"10.1016/S1773-035X(26)76716-2","DOIUrl":"10.1016/S1773-035X(26)76716-2","url":null,"abstract":"","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Page 16"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Médecine de la femme : un terme nouveau pour le SO(M)PK","authors":"Jean-Marie Manus","doi":"10.1016/S1773-035X(26)76717-4","DOIUrl":"10.1016/S1773-035X(26)76717-4","url":null,"abstract":"","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Page 17"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Steak, tique et tests : un syndrome alpha-gal débusqué","authors":"Élodie Potereau, Louise Guyot, Émeline Bruxelle, Caroline Poli, Martine Morisset, Céline Beauvillain","doi":"10.1016/S1773-035X(26)76722-8","DOIUrl":"10.1016/S1773-035X(26)76722-8","url":null,"abstract":"<div><h3>Résumé</h3><div>Le syndrome alpha-gal ou AGS (alpha-gal syndrome) est un syndrome d’hypersensibilité alimentaire et médicamenteux. Il s’agit d’une allergie au sucre galactose-alpha-1,3-galactose (alpha-gal), présent chez l’ensemble des mammifères non-primates. Cette allergie se manifeste par des anaphylaxies alimentaires différées, survenant deux à six heures après la consommation de viande de mammifères, mais également sous la forme d’anaphylaxie immédiate lors de l’utilisation de produits pharmaceutiques dérivés de mammifères. Le diagnostic repose, suite à l’interrogatoire clinique, sur des pricks-tests à la viande complétés par des dosages biologiques sériques et/ou tests d’activation des basophiles. La prise en charge inclut des mesures préventives essentielles telles que l’éviction de la consommation d’aliments contenant ce sucre.</div></div><div><h3>Abstract</h3><div>Alpha-Gal Syndrome (AGS) is a food and drug hypersensitivity disorder. Galactose-alpha-1,3-galactose (alpha-Gal), which is present in all non-primate mammals is the allergen responsible of this disorder. Exposure to mammalian meat can trigger delayed anaphylaxis, occurring two to six hours after ingestion, while mammal-derived pharmaceutical products may induce immediate anaphylactic reactions in sensitized individuals. Diagnosis is based on clinical history, meat prick-tests, complemented by serum IgE assays and/or basophil activation tests. Management primarily relies on preventive measures, including strict avoidance of foods and products containing this sugar</div></div>","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Pages 34-37"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}